<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Cell</journal-id>
      <journal-title>Molecular Cell</journal-title>
      <issn pub-type="ppub">1097-2765</issn>
      <issn pub-type="epub">1097-4164</issn>
      <publisher>
        <publisher-name>Cell Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2225447</article-id>
      <article-id pub-id-type="pmid">18206969</article-id>
      <article-id pub-id-type="publisher-id">MOLCEL2606</article-id>
      <article-id pub-id-type="doi">10.1016/j.molcel.2007.11.030</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Transcription-Dependent Gene Looping of the HIV-1 Provirus Is Dictated by Recognition of Pre-mRNA Processing Signals</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Perkins</surname>
            <given-names>Kelly J.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lusic</surname>
            <given-names>Marina</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mitar</surname>
            <given-names>Ivonne</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Giacca</surname>
            <given-names>Mauro</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Proudfoot</surname>
            <given-names>Nick J.</given-names>
          </name>
          <email>nicholas.proudfoot@path.ox.ac.uk</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="cor1" ref-type="corresp">∗</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <addr-line><sup>1</sup>Sir William Dunn School of Pathology, South Parks Road, University of Oxford, Oxford OX1 3RE, UK</addr-line>
      </aff>
      <aff id="aff2">
        <addr-line><sup>2</sup>Laboratory of Molecular Medicine, International Center for Genetic Engineering and Biotechnology, Padriciano, 99-34012 Trieste, Italy</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1"><label>∗</label>Corresponding author <email>nicholas.proudfoot@path.ox.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>18</day>
        <month>1</month>
        <year>2008</year>
      </pub-date>
      <volume>29</volume>
      <issue>1</issue>
      <fpage>56</fpage>
      <lpage>68</lpage>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>3</month>
          <year>2007</year>
        </date>
        <date date-type="rev-recd">
          <day>3</day>
          <month>7</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>11</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2008 ELL &amp; Excerpta Medica</copyright-statement>
        <copyright-year>2008</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license>
          <p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p>
        </license>
      </permissions>
      <abstract>
        <title>Summary</title>
        <p>HIV-1 provirus, either as a chromosomal integrant or as an episomal plasmid in HeLa cells, forms a transcription-dependent gene loop structure between the 5′LTR promoter and 3′LTR poly(A) signal. Flavopiridol-mediated inhibition of RNA polymerase II elongation blocks 5′ to 3′LTR juxtaposition, indicating that this structure is maintained during transcription. Analysis of mutant or hybrid HIV-1 plasmids demonstrates that replacement of the 5′LTR promoter with CMV or the 3′LTR poly(A) signal with a synthetic element (SPA) permits gene loop formation, suggesting that these interactions are not retroviral specific. In addition, activation of the 5′LTR poly(A) signal or inactivation of the 3′LTR poly(A) signal abolishes gene loop formation. Overall, we demonstrate that both ongoing transcription and pre-mRNA processing are essential for gene loop formation, and predict that these structures represent a defining feature of active gene transcription.</p>
      </abstract>
      <kwd-group>
        <kwd>DNA</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>Introduction</title>
      <p>Transcription of protein-encoding genes in eukaryotes is mediated by RNA polymerase II (Pol II) holoenzyme, where drastic alterations to its composition and activity occur during the transcription cycle. Pol II is recruited to promoters at initiation through interaction with multiple transcription factors bound to adjacent or distant regulatory elements (enhancers) by direct enhancer-promoter association, resulting in “looped” conformations that juxtapose otherwise distant genetic elements (<xref rid="bib40" ref-type="bibr">West and Fraser, 2005</xref>). Initiation structures are replaced by Pol II-associated elongation factors to promote transcription along the gene, generating nascent pre-mRNA. Central to this process is Pol II C-terminal domain (CTD) phosphorylation on serine 5 residues (Ser5) by TFIIH-associated Cdk7 and associated cyclinH (<xref rid="bib37" ref-type="bibr">Thomas and Chiang, 2006</xref>). Subsequently, elongation factor P-TEFb, comprising the kinase Cdk9 and associated cyclinT, promotes additional Ser2 phosphorylation (<xref rid="bib31" ref-type="bibr">Peterlin and Price, 2006</xref>). Specific CTD phosphorylation patterns elicit factor recruitment, which modifies underlying chromatin gene structure (<xref rid="bib29" ref-type="bibr">Mellor, 2006</xref>), promoting cotranscriptional capping, splicing, cleavage, and polyadenylation of the pre-mRNA (<xref rid="bib33" ref-type="bibr">Proudfoot et al., 2002</xref>).</p>
      <p>Many features of this process are defined for HIV-1 (<xref rid="bib26" ref-type="bibr">Marcello et al., 2004</xref>). The long-terminal repeat (LTR) sequence located at either end of the provirus is divided into three regions, of which U3 contains enhancer and promoter activity, including DNA binding sites for transcription factors USF, NF-κB, and SP1. Full transcription from the 5′LTR requires expression of the virally encoded Tat protein that acts through binding an RNA stem-loop structure called TAR (formed by transcription of the 5′LTR “R” sequence). NF-κB and Tat recruit P-TEFb to TAR and enhance transcriptional elongation (<xref rid="bib31" ref-type="bibr">Peterlin and Price, 2006</xref>). Finally, R and U5 sequences promote cleavage and polyadenylation of HIV-1 mRNA in the 3′LTR (<xref rid="bib7" ref-type="bibr">Bohnlein et al., 1989</xref>). Identical sequences in the 5′LTR are blocked from processing activity through interaction with the adjacent major splice donor site (MSD) located 190 nucleotides 3′ to the 5′LTR region (<xref rid="bib3 bib4" ref-type="bibr">Ashe et al., 1995, 1997</xref>).</p>
      <p>Several Pol II-transcribed yeast genes adopt a circular conformation associated with transcriptional activation (<xref rid="bib2 bib30" ref-type="bibr">Ansari and Hampsey, 2005; O'Sullivan et al., 2004</xref>). This requires phosphorylated CTD and cleavage/poly(A) factors, which may act as a bridge between the promoter and 3′ end to enhance specificity and/or efficiency of gene transcription. We now demonstrate with chromosome conformation capture (3C) and chromatin immunoprecipitation (ChIP) that integrated HIV-1 provirus induced via cellular (TPA-mediated) or viral (Tat) means shows the existence of looping conformations. Furthermore, inhibiting P-TEFb by flavopiridol (<xref rid="bib11" ref-type="bibr">Chao and Price, 2001</xref>) severely affects gene loop formation. We also show identical transcription-dependent HIV-1 gene loops form on plasmid DNA by using adapted 3C methodology (plasmid 3C; p3C) in HeLa cells.</p>
      <p>Using p3C we show that loop formation was unaffected by replacing either the 5′LTR U3 promoter with the CMV promoter or the 3′LTR with a heterogeneous synthetic poly(A) (SPA) site. Consequently, these interactions are not uniquely a property of retroviruses such as HIV-1. We also show that switching polyadenylation from the 3′LTR to 5′LTR (by MSD mutation) causes a loss of proviral looping. Processing elements involved in 5′-3′ juxtaposition were defined by mutating the endogenous 3′LTR or SPA element, both of which specifically affect looping. Our studies reveal that ongoing transcription and pre-mRNA processing are essential for gene loop formation.</p>
    </sec>
    <sec id="sec2">
      <title>Results and Discussion</title>
      <sec id="sec2.1">
        <title>RNA Pol II Is Asymmetrically Distributed along Transcriptionally Active HIV-1 Provirus</title>
        <p>We used the promonocytic U937 cell line U1 (<xref rid="bib16" ref-type="bibr">Folks et al., 1987</xref>), which contains two copies of integrated HIV-1 provirus on the short arm of chromosome X and on a rearranged chromosome 6 (<xref rid="bib13" ref-type="bibr">Deichmann et al., 1997</xref>). U1 cells produce very low levels of HIV-1 mRNA under basal conditions, due to defective viral <italic>trans</italic>-activator Tat mRNAs (Tat1<sub>U1</sub>; mutated initiation codon, Tat2<sub>U1</sub>; H<sub>13</sub>L substitution [<xref rid="bib15" ref-type="bibr">Emiliani et al., 1998</xref>]). Integrated proviral expression also depends on the surrounding chromatin environment and interaction of the viral Tat <italic>trans</italic>-activator with host factors (<xref rid="bib26" ref-type="bibr">Marcello et al., 2004</xref>). U1 latent proviral transcription can be markedly induced by exogenous Tat expression (<xref rid="bib15" ref-type="bibr">Emiliani et al., 1998</xref>) or exposure to the phorbol ester TPA, which induces NF-κB heterodimers to bind within the LTR U3 region (<xref rid="bib25" ref-type="bibr">Lusic et al., 2003</xref>). Both stimuli cause substantial modification of chromatin structure over the viral 5′LTR promoter (<xref rid="bib25" ref-type="bibr">Lusic et al., 2003</xref>). Taqman qRT-PCR analysis of U1 RNA after TPA stimulation showed that levels of viral mRNA rose rapidly (400-fold; <xref rid="fig1" ref-type="fig">Figure 1</xref>Aa) within 24 hr and further increased up to 7 days.</p>
        <p>To analyze proviral transcription in the context of the surrounding chromatin environment, finer mapping was necessary. An inverse PCR strategy was employed (<xref rid="bib12" ref-type="bibr">Chun et al., 1997</xref>) to map U1 integrates to Xp11.4 and 2p16.3 (<xref rid="fig1" ref-type="fig">Figure 1</xref>B); the latter arising from the reciprocal translocation of t(2;6)(p13;p21) (<xref rid="bib23" ref-type="bibr">Lee et al., 2002</xref>). Integrates are thus referred to as int-ChrX and int-Chr2. Additional iPCR analysis allocated Tat1<sub>U1</sub> to int-Chr2 and Tat2<sub>U1</sub> to int-ChrX (<xref rid="fig1" ref-type="fig">Figure 1</xref>Bb). Database analysis indicates int-Chr2 and int-ChrX are positioned in transcriptionally silent genomic regions.</p>
        <p>U1 HIV-1 proviral Pol II levels were analyzed by quantitative real-time ChIP (qChIP) (<xref rid="fig1" ref-type="fig">Figure 1</xref>Ac). Untreated samples showed Pol II occupancy is largely restricted to the 5′LTR, consistent with previous studies (<xref rid="bib20" ref-type="bibr">Gomes et al., 2006</xref>). TPA treatment showed increased, but asymmetric amounts of Pol II across the HIV-1 provirus, with the strongest signals observed at P1 and adjacent region, nuc1. Distribution was marked by a concurrent increase in bound Pol II within the 3′LTR proximal region (G) and its relative absence from the proviral body, which is maintained at the 24 hr TPA induction time, paralleling sustained provirus transcriptional activity (<xref rid="fig1" ref-type="fig">Figure 1</xref>Ac). Induced int-ChrX showed 5-fold higher levels of Pol II occupancy at the 3′ end of the provirus (X3′) than int-Chr2 (23′), indicating that chromatin environment may influence levels of asymmetric Pol II distribution.</p>
      </sec>
      <sec id="sec2.2">
        <title>Integrated HIV-1 Provirus Exists in a Looped Chromatin Conformation</title>
        <p>In yeast, a similar Pol II profile after transcriptional activation was observed across the <italic>FMP27</italic> gene of <italic>S. cerevisiae</italic> (<xref rid="bib30" ref-type="bibr">O'Sullivan et al., 2004</xref>), caused by physical interaction between the promoter and 3′ region. We therefore investigated the spatial proximity of proviral regulatory regions under basal or TPA/Tat-induced conditions by using 3C (<xref rid="bib14" ref-type="bibr">Dekker et al., 2002</xref>). Briefly, 3C defines the proximity between different regions along or between chromosomes by crosslinking chromatin with formaldehyde. Chromatin is then fragmented by a chosen restriction enzyme, diluted to limit random intermolecular interactions, and ligated to covalently join DNA fragments crosslinked to the same complex (intramolecular ligation).</p>
        <p>We used int-ChrX or int-Chr2 flanking primers with internal proviral primers (<xref rid="fig2" ref-type="fig">Figure 2</xref>A) to discriminate between integrates. Chromatin preparations were digested with BanI or HindIII restriction enzymes from noninduced or TPA-treated cells, which increase transcript levels 11-fold (<xref rid="fig2" ref-type="fig">Figure 2</xref>Ca). Representative gels of 3C PCR products obtained under noninduced and stimulated conditions are shown in <xref rid="fig2" ref-type="fig">Figure 2</xref>B, where positive control lanes show expected PCR products from the intramolecular ligation of BanI- or HindIII-digested fragments and graphs indicate percentage products compared to the PCR control. Upon TPA induction, a specific increase in 3C products was apparent for int-ChrX with BanI- and HindIII-digested chromatin. With BanI, stronger 3C products were observed, specifying the close spatial proximity of the 5′LTR with the 3′LTR (using primers X3/X2) and both LTRs with the adjacent fragment to the 5′LTR containing the MSD (primers X3/B1 and X2/B1 respectively). All 3C products were defined by DNA sequencing. Untreated cells showed low levels of the same products, consistent with the presence of low, albeit detectable, full-length HIV-1 mRNAs under basal conditions (<xref rid="bib22" ref-type="bibr">Jeang et al., 1993</xref>).</p>
        <p>HindIII int-ChrX analysis (<xref rid="fig2" ref-type="fig">Figure 2</xref>B) gave a similar profile to BanI: 3C PCR products were detected with primers that detect interactions between the 5′LTR and 3′LTR (X3/X2) and with the adjacent fragment containing the MSD (X3/H4 and X2/H4). As a HindIII site is positioned between the U3/R and U5 region (<xref rid="fig2" ref-type="fig">Figure 2</xref>A), both the LTR-LTR interaction and 5′LTR U3 and R region with its adjacent fragment containing the U5 and MSD could be more precisely defined (primers H4/X3). As shown in <xref rid="fig2" ref-type="fig">Figure 2</xref>B, the principal 3C product amplified was obtained with the primers X3/X2 and indicates an interaction between the 5′LTR U3 and R region with the U5 region of the 3′LTR.</p>
        <p>To determine whether interactions defined by 3C were restricted to the LTRs and their flanking regions or if internal regions of the HIV-1 provirus interact with each other, we performed intraproviral analysis. We also performed interchromosomal 3C analysis to investigate whether the two integrates interact (<xref rid="fig2" ref-type="fig">Figure 2</xref>B). Neither analysis resulted in significantly detectable products, demonstrating that loop formation appears to be both discrete to each integrate and largely restricted to fragments encompassing duplicated LTRs and short flanking chromosomal regions.</p>
      </sec>
      <sec id="sec2.3">
        <title>int-ChrX and int-Chr2 Proviruses Show Quantitative Differences in Gene Loop Formation</title>
        <p>ChIP data show that, in contrast to int-ChrX, Pol II signals adjacent to the 3′LTR of int-Chr2 remain at basal levels after TPA stimulation, suggesting that gene loop formation is less pronounced (<xref rid="fig1" ref-type="fig">Figure 1</xref>Ac). We analyzed int-Chr2-specific 3C products with BanI-digested chromatin (<xref rid="fig2" ref-type="fig">Figure 2</xref>B). 3C interactions were detectable between the LTRs but did not change significantly upon TPA stimulation. We did, however, observe some increase in the 3C interaction between both LTRs and the MSD (primers 23/B1 and 22/B1). To compare relative levels of gene loop formation between integrates after transcriptional activation, we employed quantitative real-time 3C (q3C) analysis of HindIII-digested chromatin from 5 hr TPA-treated U1 cells. As shown in <xref rid="fig2" ref-type="fig">Figure 2</xref>Cb, a modest increase in the 5′-3′LTR 3C product from int-Chr2 was observed over basal levels after activation, whereas int-ChrX showed a significantly higher increase. The difference between integrates was more striking when promoter-terminator interactions were compared to amplification of an adjacent fragment by using 22 (int-Chr2) and X2 (int-ChrX) with H7 (3.7-fold for int-Chr2 and 63-fold for int-ChrX).</p>
      </sec>
      <sec id="sec2.4">
        <title>Tat-Mediated HIV-1 Transcriptional Activation Also Stimulates Loop Formation</title>
        <p>HIV-1 transcription is enhanced by the viral Tat <italic>trans</italic>-activator through interaction with the 5′LTR TAR transcript (<xref rid="bib31" ref-type="bibr">Peterlin and Price, 2006</xref>). Tat-associated TAR is known to augment transcriptional initiation and elongation of Pol II. These are mediated by Tat interaction with nuclear proteins possessing chromatin remodeling activity and cellular kinases (most notably, P-TEFb), which phosphorylate the Pol II CTD (<xref rid="bib26" ref-type="bibr">Marcello et al., 2004</xref>).</p>
        <p>We thus compared the effect of Tat- versus TPA-mediated induction on HIV-1 gene loop formation. As both integrates have a defective <italic>tat</italic> sequence (<xref rid="fig1" ref-type="fig">Figure 1</xref>B), Tat was supplied in <italic>trans</italic> by electroporation of a Tat-GFP expression vector. GFP-Tat <italic>trans</italic>-activation resulted in a 16-fold stimulation of HIV-1 mRNA levels (<xref rid="fig2" ref-type="fig">Figure 2</xref>Da). We undertook HindIII q3C analysis and observed Tat-dependent 3C products, indicating gene loop formation over both proviral integrates (<xref rid="fig2" ref-type="fig">Figure 2</xref>Db). Weaker LTR-MSD interactions were also detected (primers 23/H4 and X2/H4). Again, int-ChrX gave a much higher response than int-Chr2 to exogenous Tat (12-fold as compared to 4-fold). This result parallels TPA induction and suggests HIV-1 gene loop formation is a feature of transcriptional initiation and elongation.</p>
        <p>Results obtained from 3C analysis thus demonstrate the existence of two transcription-dependent proviral conformations. First, a promoter-poly(A) signal interaction occurs across the provirus, signifying that loop formation is separate to the site of transcriptional termination, which occurs at least 1 kb downstream of both integrate 3′LTRs as determined by RT-PCR (data not shown). A second interaction is observed between both LTRs and a proviral sequence adjacent to the 5′LTR containing the MSD. These results are summarized as a ribbon diagram (<xref rid="fig7" ref-type="fig">Figure 7</xref>A).</p>
      </sec>
      <sec id="sec2.5">
        <title>HIV-1 Gene Loops Are Detected by Plasmid 3C Analysis of Transfected HIV-1 Provirus</title>
        <p>We initially considered that HIV-1 proviral gene loops may depend on their chromatin environment. However, difficulty in manipulating specific sequences in a genomic context encouraged us to determine if looping could be demonstrated on a transfected template. Plasmids have been shown to adopt nuclear plasmid transcription domains separate from chromosomal territories (<xref rid="bib6" ref-type="bibr">Binnie et al., 2006</xref>). We transfected the proviral plasmid pNL4-3 (<xref rid="bib1" ref-type="bibr">Adachi et al., 1986</xref>) into HeLa cells and showed that HIV-1-specific transcripts were detectible by RT-PCR analysis after 48 hr (<xref rid="fig3" ref-type="fig">Figure 3</xref>Aa).</p>
        <p>To detect specific pNL4-3 loop products, we adapted 3C into a plasmid 3C technique (p3C), which requires additional purification steps by repeated centrifugation through sucrose cushions necessary to remove excess transfected cytoplasmic plasmid accumulated around the nuclear periphery. We performed BanI p3C with internal HIV-1 primers previously used for chromosomal 3C analysis (<xref rid="fig2" ref-type="fig">Figure 2</xref>A) with pUC18 vector primers p1–p5 (<xref rid="fig3" ref-type="fig">Figure 3</xref>Ab). Identical p3C products were detected as seen with transcriptionally activated HIV-1 chromosomal integrants (<xref rid="fig3" ref-type="fig">Figure 3</xref>B). Thus, primer p3 (5′LTR) amplified specific 3C products with primers H4 and p2, showing the same MSD and 3′LTR interaction. Other primer combinations confirmed these findings and were subsequently reproduced with quantitative real-time p3C analysis (q-p3C; see <xref rid="fig6" ref-type="fig">Figure 6</xref>). Although adjacent BanI fragments did occasionally amplify 3C products (denoted by x; <xref rid="fig3" ref-type="fig">Figure 3</xref>B), most primer pairs unrelated to MSD or LTR interactions gave only background 3C levels. These negative controls are striking, as plasmids transcribing homologous sequences colocalize into plasmid transcription domains (<xref rid="bib6" ref-type="bibr">Binnie et al., 2006</xref>). As specific gene loop products were detectable between proviral LTR and LTR-MSD regions, we suggest that this phenomenon is occurring in <italic>cis</italic>. These results are consistent with the lack of intrachromosomal 3C signal between int-ChrX and int-Chr2 in U1 cells (<xref rid="fig2" ref-type="fig">Figure 2</xref>B). Combined 3C and p3C analyses show that major interactions occur between the 5′LTR U3 promoter and 3′LTR U5 poly(A) signal as well as between each LTR and the 5′ positioned MSD signal (Figures <xref rid="fig3" ref-type="fig">3</xref>C and <xref rid="fig7" ref-type="fig">7</xref>B).</p>
      </sec>
      <sec id="sec2.6">
        <title>Loop Formation Is Reflected in Pol II CTD Phospho-Ser2 and -Ser5 Distribution</title>
        <p>Pol II CTD phosphorylation changes through the transcription cycle and is involved in several postinitiation steps (<xref rid="bib28" ref-type="bibr">Meinhart et al., 2005</xref>). We therefore tested whether loop formation correlates with Pol II CTD phosphorylation and thus with polymerase processivity. qChIP analysis with antibodies recognizing phospho-Ser5 (Ser5P) showed barely detectable levels at the promoter and absence from the proviral body for noninduced U1 cells (<xref rid="fig4" ref-type="fig">Figure 4</xref>Aa). Upon activation, Ser5P was present throughout the provirus with the highest occupancy (almost 2-fold higher) at the 5′LTR and 3′LTR regions. Consistent with high levels of viral transcription (<xref rid="fig1" ref-type="fig">Figure 1</xref>A), high Ser5 levels persisted for longer time periods (24 hr TPA induction; <xref rid="app2" ref-type="sec">Figure S1</xref> available online).</p>
        <p>Upon transcriptional activation, very low amounts of Ser2 were detected within the provirus (<xref rid="fig4" ref-type="fig">Figure 4</xref>Ab), with a higher, asymmetric distribution pattern in particular over the 5′ and 3′LTRs (nuc1 and G, respectively). The highest signal was detected by P1 primers in both 5′ and 3′LTR regions. In agreement with studies on HIV-1 LTR reporter genes (<xref rid="bib8" ref-type="bibr">Bres et al., 2005</xref>), higher Ser2P levels were detected in the proviral body during longer, 24 hr TPA induction times (<xref rid="app2" ref-type="sec">Figure S1</xref>). The observation that Ser2P/Ser5P is more easily detected than total RNAP II in the proviral body after TPA induction (<xref rid="fig1" ref-type="fig">Figure 1</xref>Ac) is consistent with studies on other cellular genes (<xref rid="bib20" ref-type="bibr">Gomes et al., 2006</xref>). Asymmetric distribution of Ser2P/Ser5P also mirrors 3C data showing that 5′ and 3′LTRs are juxtaposed. Moreover, qChIP data are consistent with our observation that the integrates differ in their response to transcriptional stimuli as stronger Ser2P/Ser5P ChIP signals are observed at the earlier TPA induction time for the int-ChrX provirus (<xref rid="fig4" ref-type="fig">Figures 4</xref>Aa and 4Ab). Together these data indicate that int-ChrX displays higher transcriptional inducibility and activity.</p>
        <p>To confirm Ser2P/Ser5P profiles, anti-CDK9 qChIP detected small amounts of CDK9 in the 5′LTR under basal conditions <bold>(</bold><xref rid="fig4" ref-type="fig">Figure 4</xref>Ac), consistent with studies that show CDK9 at promoter regions of transcriptionally inactive human genes (<xref rid="bib20" ref-type="bibr">Gomes et al., 2006</xref>). TPA induction (5 hr) causes CDK9 accumulation at both ends of the provirus with a more even distribution across the provirus at 24 hr (<xref rid="app2" ref-type="sec">Figure S1</xref>). Consequently, CDK9 distribution patterns mirror those of Ser2P. As H<sub>13</sub>L-substituted Tat (int-ChrX) retains some of its <italic>trans</italic>-activating activity, TPA-induced proviral expression results in production of endogenous Tat protein in U1 cells, effectively making these cells a complete HIV-1 transcription environment. We predict that Tat activity shifts CDK9 phosphorylation from Ser2P to Ser2P/Ser5P, explaining the marked similarity of their ChIP profiles with CDK9 (<xref rid="fig4" ref-type="fig">Figures 4</xref>Aa–4Ac). Finally, we analyzed upstream stimulatory factor (USF), which binds the HIV-1 LTR U3 region (<xref rid="fig1" ref-type="fig">Figure 1</xref>Ab) irrespective of the transcriptional state of the provirus (<xref rid="bib19" ref-type="bibr">Giacca et al., 1992</xref>). Under both noninduced and TPA-activated conditions, USF was strongly detected at the 5′LTR and more weakly at the 3′LTR of the viral genome, consistent with a model in which for the uninduced state, hypophosphorylated Pol II binds the 5′LTR region (<xref rid="fig4" ref-type="fig">Figure 4</xref>Ad).</p>
        <p>As proviral expression is dependent on the surrounding chromatin environment (<xref rid="bib26" ref-type="bibr">Marcello et al., 2004</xref>), we analyzed the flanking 16 kb region of both integrates with qChIP (<xref rid="fig4" ref-type="fig">Figure 4</xref>B). Although there was little change in the int-Chr2 profile (<xref rid="fig4" ref-type="fig">Figure 4</xref>Bb), int-ChrX showed significant increases in both Pol II and Ser2P occupancy at the 3′LTR upon 5 hr TPA treatment. Thus, differences in loop formation may arise from flanking regions influencing the ability of integrated provirus to respond to transcriptional stimuli.</p>
      </sec>
      <sec id="sec2.7">
        <title>HIV-1 Long-Terminal Repeat Juxtaposition Is Dependent on Ongoing Transcription</title>
        <p>To strengthen our observations that gene loop structures exist only when HIV-1 provirus is transcriptionally active, we used the drug flavopiridol, which specifically represses CDK9 kinase activity, resulting in its inability to phosphorylate the Pol II CTD (<xref rid="bib11" ref-type="bibr">Chao and Price, 2001</xref>). HIV-1 transcription was induced by 16 hr TPA treatment and then blocked by further treatment with flavopiridol for 5 hr (<xref rid="fig5" ref-type="fig">Figure 5</xref>Aa). We performed q3C, focusing on formation of int-Chr2 and int-ChrX proviral gene loops. Consistent with the original 3C analysis (<xref rid="fig2" ref-type="fig">Figure 2</xref>C), int-Chr2 provirus forms a weakly inducible gene loop after 16 hr TPA induction (primers 22 and 23), whereas int-ChrX forms a strongly inducible gene loop (primers X2 and X3). Dramatically, TPA-stimulated cells treated with flavopiridol for 5 hr caused 3C signal levels to drop to control (unstimulated) levels for both proviruses, suggesting that ongoing transcriptional elongation is indeed required for gene loop maintenance. This was strengthened by additional studies on chromatin from cells subjected to flavopiridol treatment in the absence of TPA induction in which 3C products corresponding to low levels of HIV-1 looping in untreated U1 (control) cells were significantly reduced (<xref rid="app2" ref-type="sec">Figure S2</xref>).</p>
        <p>To verify that transcriptional inhibition correlates with blocking CDK9 kinase activity, we performed a full set of qChIP experiments under these conditions. Flavopiridol treatment caused a predicted loss of CDK9 across the proviral genome and Ser2P/Ser5P from the integrated provirus, supporting the observation that CDK9 acts on CTD Ser2 and Ser5 in transcriptionally activated U1 cells (<xref rid="fig5" ref-type="fig">Figures 5</xref>C–5E). Significantly, HIV-1 proviral distribution pattern for total Pol II and USF was differentially affected by flavopiridol treatment (<xref rid="fig5" ref-type="fig">Figures 5</xref>B and 5F). Instead of reducing all signals to low levels, Pol II and USF signals were selectively lost from the proviral body and 3′ flank but were maintained over both LTR regions (P1) and immediately downstream from the 5′LTR transcription start site (nuc1). These data therefore support the view that gene loop formation is consequent to formation of the USF-dependent Pol II initiation complex.</p>
      </sec>
      <sec id="sec2.8">
        <title>HIV-1 Gene Loop Formation Is Dependent on Competing 5′ and 3′LTR Poly(A) Site Recognition</title>
        <p>With the development of the plasmid 3C technique (<xref rid="fig3" ref-type="fig">Figure 3</xref>), we directly manipulated HIV-1 sequences required for gene loop formation. We analyzed a noninfectious pNL4 derivative (pNL4-3.R-E-; henceforth called pNL4-luc) and the effect of activating the 5′LTR poly(A) signal by inactivating the MSD. Normally, the MSD suppresses the 5′LTR poly(A) signal through the negative interaction of U1snRNP 70 kDa subunit (<xref rid="bib5" ref-type="bibr">Ashe et al., 2000</xref>; <xref rid="app2" ref-type="sec">Figure S3</xref>). Furthermore, U1snRNP recognition requires definition of a complete intron transcript, including 3′ splicing signals (<xref rid="bib3" ref-type="bibr">Ashe et al., 1995</xref>). We mutated the pNL4 MSD (<xref rid="app2" ref-type="sec">Figure S3</xref>A), confirmed that the 5′LTR poly(A) signal was used by RNase protection analysis (RPA; <xref rid="app2" ref-type="sec">Figure S3</xref>B), and performed BanI q-p3C analysis (<xref rid="fig6" ref-type="fig">Figure 6</xref>Ab). Dramatically, MSD point mutation significantly affected both gene loop conformations. In effect, the pNL4 plasmid loses its contorted structure associated with the two gene loops and adopts a more open circular conformation. This structural switch correlates with a switch in transcript length from full-length HIV-1 transcripts utilizing the 3′LTR poly(A) signal to a short transcript that utilizes the 5′LTR poly(A) signal (<xref rid="fig7" ref-type="fig">Figure 7</xref>D). As pNL4-luc gave comparable results to those observed for pNL4 (<xref rid="fig6" ref-type="fig">Figure 6</xref>Ab), it was used as a template for further mutational analysis.</p>
      </sec>
      <sec id="sec2.9">
        <title>HIV-1 Gene Loop Formation Is LTR Independent but Requires a Functional 3′ Poly(A) Signal</title>
        <p>We wished to determine whether 5′-3′ gene looping was unique to retroviruses such as HIV-1, which differ from normal transcription units in being flanked by identical LTR sequences. We therefore replaced the 5′ HIV-1 U3 promoter with a CMV promoter (<xref rid="fig6" ref-type="fig">Figure 6</xref>Aa), while maintaining the 3′LTR poly(A) site. 5′-3′ juxtaposition was unaffected (1.08-fold increase compared to wild-type pNL4-luc; <xref rid="fig6" ref-type="fig">Figure 6</xref>Ac). However, a 2.5-fold drop in 5′LTR/MSD product was observed, which may arise from the lack of the 5′ R/U5 region amplified by the 5′LTR p3 primer. R contains the TAR element, which is a known influence in efficiency of 5′ poly(A) site suppression (<xref rid="bib18" ref-type="bibr">Furger et al., 2001</xref>).</p>
        <p>As mutating the MSD directly influences transcription by poly(A) site usage, the ability of Pol II to reach the 3′LTR may be affected. Loss of loop products could therefore be linked to the lack of an intact RNA extending between the 5′ and 3′LTR. We therefore analyzed a number of 3′ end constructs and their effect on loop formation, while maintaining the 5′LTR (<xref rid="fig6" ref-type="fig">Figure 6</xref>B). Using RPA analysis, we determined that these constructs did not utilize the 5′ poly(A) site and are expected to produce transcripts that reach the 3′LTR (data not shown). We cotransfected a Tat expression vector to prevent any alteration in transcription rates of the mutants caused by potential defective processing of Tat mRNA. Two 3′LTR poly(A) signal mutants were analyzed (<xref rid="fig6" ref-type="fig">Figure 6</xref>Bb): one inactivating the essential hexamer sequence (AAUAAA to AACAAA; pNL4-luc.pA) and the other removing the U5 region containing the GU-rich DSE element (pNL4-luc.DSE). Mutation of the 3′ poly(A) hexamer resulted in a 3-fold decrease in 5′-3′ LTR p3C product while maintaining wild-type values between the 5′LTR-MSD (0.95-fold; <xref rid="fig6" ref-type="fig">Figure 6</xref>Bc). This shows poly(A) site recognition is essential for juxtaposition of the 5′-3′ region. Interestingly pNL4-luc.DSE showed little change (0.9-fold for both the 5′-3′LTR and 5′LTR-MSD compared to pNL4-luc), which may be explained by the presence of a redundant GU-rich sequence brought in close proximity to the hexamer after DSE deletion (<xref rid="app2" ref-type="sec">Figure S5</xref>i). We extended this analysis by replacing the 3′LTR with a heterologous strong synthetic poly(A) (SPA) site (<xref rid="bib24" ref-type="bibr">Levitt et al., 1989</xref>) while maintaining the 5′LTR (<xref rid="fig6" ref-type="fig">Figures 6</xref>Ba and 6Bb). Interestingly, p3C analysis showed that replacing the entire 3′LTR region with SPA is not detrimental to 5′-3′ juxtaposition (1.4-fold increase). Conversely, the nonfunctional SPA site (pNL4-luc.SPAmt) abolishes this interaction more effectively than the endogenous poly(A) mutant (4.5-fold decrease). However, it may be possible that the presence of a weaker AAUAAA signal within the U3 region of the 3′LTR (<xref rid="app2" ref-type="sec">Figure S5</xref>ii) could partially compensate as a cryptic poly(A) site in the pNL4-luc.pA mutant. In addition, values obtained for B1/p3 products may be affected by the detection of circularized partial digestion products. We therefore performed p3C analysis with a primer facing in the same direction as p3 (H4.1) for all constructs (<xref rid="app2" ref-type="sec">Figure S4</xref>) and obtained comparable values. Overall results from p3C analysis allow us to conclude that HIV-1 gene loop formation requires coupled pre-mRNA processing.</p>
      </sec>
      <sec id="sec2.10">
        <title>Conclusions</title>
        <p>We have demonstrated that a specific gene loop conformation is imposed on integrated HIV-1 provirus after transcriptional activation and that different chromosomal contexts of these two integrates modulates both transcriptional levels and the consequent capacity to form gene loop structures. U1 int-Chr2 provirus is only weakly inducible by TPA or Tat and forms lower levels of gene looping that only increase a few fold after induction (<xref rid="fig2" ref-type="fig">Figures 2</xref>C and 2D). This correlates with relatively low levels of transcription apparatus associated with this provirus before or after TPA induction (based on ChIP analysis, Figures <xref rid="fig1" ref-type="fig">1</xref>A and <xref rid="fig4" ref-type="fig">4</xref>A). Instead, int-ChrX provirus is strongly activated by TPA showing higher levels of active Pol II, CDK9, and USF recruitment and a commensurate high level of gene loop conformation (<xref rid="fig2" ref-type="fig">Figure 2</xref>). Another conformational change observed for both proviral genomes was detected between their LTRs and the MSD region adjacent to the 5′LTR (<xref rid="fig2" ref-type="fig">Figure 2</xref>B), presumably reflecting the functional interplay between the MSD and 5′LTR poly(A) signal (<xref rid="bib3 bib4" ref-type="bibr">Ashe et al., 1995, 1997</xref>). These data have also been extended and confirmed by p3C analysis (<xref rid="fig3 fig6" ref-type="fig">Figures 3 and 6</xref>). That we observe specific LTR-LTR and LTR-MSD interactions argues that these gene conformations are not dictated by specific chromatin structures but rather are permissively formed across the proviral genome as long as there is ongoing transcription. Strikingly, p3C analysis demonstrates that gene loop formation is entirely dependent on interplay between pre-mRNA splicing and alternative polyadenylation, as exemplified by retroviruses such as HIV-1. As inactivation of the MSD causes a significant drop in both gene loops; these structures appear to not only depend on ongoing transcription but also act to define the correct RNA processing pattern to allow effective HIV-1 gene expression. This is confirmed by direct mutation of the 3′LTR poly(A) hexamer, which also causes a significant loss of LTR-LTR juxtaposition. Furthermore, either the 5′LTR promoter or 3′LTR poly(A) signal can be functionally replaced with heterologous elements and still maintain full gene loop levels.</p>
        <p>Applying 3C analysis to investigate long-range associations between noncontiguous chromosomal segments has become widespread. Clustering of coregulated genes has been reported (<xref rid="bib34 bib41" ref-type="bibr">Simonis et al., 2006; Zhao et al., 2006</xref>), suggesting the existence of so-called transcription “factories” (<xref rid="bib32" ref-type="bibr">Pombo et al., 2000</xref>). Also, substantial distances between gene regulatory sequences (enhancers) and target promoters can be explained by their 3D juxtaposition detected by 3C analysis (<xref rid="bib17 bib36 bib39" ref-type="bibr">Fraser, 2006; Splinter et al., 2004; Vakoc et al., 2005</xref>). For example, the interleukin gene cluster in mouse has specific chromosomal structures called SATBs, required for gene expression, and looping with their adjacent genes promotes effective gene expression (<xref rid="bib9" ref-type="bibr">Cai et al., 2006</xref>). However, our study reports a different type of gene conformation, reflecting the dynamic structural changes associated with the actual transcription process. We first reported this phenomenon for <italic>S. cerevisiae</italic> (<xref rid="bib30" ref-type="bibr">O'Sullivan et al., 2004</xref>) where <italic>FMP27</italic> gene loop formation was shown to be dependent on Pol II CTD Ser5P and kinase Kin28p. It also appears that that specific poly(A) factors (Ssu72p and Pta1) are required for loop formation (<xref rid="bib2" ref-type="bibr">Ansari and Hampsey, 2005</xref>). Furthermore, recent results also imply a role for TFIIB in gene loop formation (<xref rid="bib35" ref-type="bibr">Singh and Hampsey, 2007</xref>). Finally, in the human mitochondrial episomal genome, a promoter-terminator loop juxtaposition on the heavy strand depends on the transcription factor mTERF, required for rRNA transcription initiation and termination (<xref rid="bib27" ref-type="bibr">Martin et al., 2005</xref>). Our studies extend this gene loop phenomenon to higher eukaryotes, to an integrated viral genome, and on a plasmid template. The generality of transcription-dependent gene loops in eukaryotes is therefore predicted.</p>
        <p>Whether gene loop structures are a cause or a consequence of the transcription process has yet to be determined. However, additional insights derive from this study. First, potent inhibition of gene loop formation by flavopiridol treatment, which blocks transcription elongation, but not formation, of the Pol II preinitiation complex, is important. This is judged by the continued presence of USF and Pol II on the HIV-1 5′LTR promoter even after loop destruction. These data argue, at least for HIV-1 transcription, that the early elongation phase is essential for gene loop formation. Second, these observations indicate that loop structure appears unstable, requiring ongoing transcription for maintenance. Third, we have discovered a direct connection between pre-mRNA processing and gene loop formation. Clearly, recognition of the poly(A) signal is required for gene loop formation, and this is itself dependent on coupled splice site recognition. We thus propose that gene loop structures constitute an integral part of defining a successful vertebrate gene transcription unit.</p>
      </sec>
    </sec>
    <sec sec-type="materials-methods" id="sec3">
      <title>Experimental Procedures</title>
      <sec id="sec3.1">
        <title>HIV-1 Inverse PCR Analysis</title>
        <p>Chromosomal regions flanking U1-(U937) cell line proviral integrates were defined according to <xref rid="bib12" ref-type="bibr">Chun et al. (1997)</xref>. U1 genomic DNA (2 μg) was digested with PstI (New England Biolabs) for 5 hr at 37°C, with 200 ng ligated overnight at 4°C. Ten nanograms of DNA was used in a PCR with primers across the viral genome and host cell DNA, then a nested reaction was performed with HIV-1 primers (<xref rid="bib21" ref-type="bibr">Han et al., 2004</xref>). Tat status was determined with AflIII-digested DNA by using a primer 5′ to the Tat first exon with int-ChrX/2 primers proximal to HIV-1 5′LTR chromosomal AflIII sites. 3′ flanking regions were defined by using a HIV-1 primer spanning nef/U3 (nt9091-9197) and primers specific to int-ChrX/2. All PCR products were fully sequenced. Primer sequences and locations are available in the <xref rid="app2" ref-type="sec">Supplemental Data</xref>.</p>
      </sec>
      <sec id="sec3.2">
        <title>Plasmid Constructs</title>
        <p>Recombinant HIV-1 pNL4-3 plasmid (<xref rid="bib1" ref-type="bibr">Adachi et al., 1986</xref>) used in p3C/integrated into the U1-(U937) monocytic cell line (U1) and the MSD-positive vector control (<xref rid="bib3" ref-type="bibr">Ashe et al., 1995</xref>) have been previously described. All pNL4-3 and pNL4-3.R-E- derivatives were created as described in the <xref rid="app2" ref-type="sec">Supplemental Data</xref>. RT-PCR analysis on transfected HeLa RNA used primers and conditions as described (<xref rid="bib10" ref-type="bibr">Cannon et al., 1994</xref>).</p>
      </sec>
      <sec id="sec3.3">
        <title>Tissue Culture</title>
        <p>U1 and HeLa cells were maintained at low-passage level in RPMI 1640 (+20 mM <sc>l</sc>-glutamine, 10% FCS). U1 cells (density 5 × 10<sup>5</sup>) were treated with 10<sup>−7</sup>M TPA (Sigma) for the times indicated. HeLa cells (2 × 10<sup>7</sup>) were transfected with 5 μg pNL4-3/pNL4-3.R-E- proviral constructs or pUC18 control using Fugene (Roche). 0.5 μg Tat expression vector (<xref rid="bib4" ref-type="bibr">Ashe et al., 1997</xref>) was cotransfected for pNL4-3.R-E- 3′ mutant studies. Tat-GFP/GFP control plasmids (<xref rid="bib25" ref-type="bibr">Lusic et al., 2003</xref>) were electroporated into U1 (1 × 10<sup>7</sup>) cells (Gene Pulser, Biorad) with transfection efficiency measured by FACS analysis. At time points indicated, cells were washed twice with 1×PBS for RNA purification or resuspended in fresh medium and crosslinked for ChIP and 3C analysis. Flavopiridol-treated samples were obtained by treating cells with TPA (1 × 10<sup>−7</sup>M) for 16 hr and then adding 500 nM flavopiridol for 5 hr (Division of AIDS, NIAID, NIH). HIV-1 transcript levels were measured with TaqMan (qRT-PCR) using HIV-1 nuc1 primers and housekeeping gene controls (GAPDH/18SrRNA) on an AbiPrism 7000 machine (Applied Biosystems).</p>
      </sec>
      <sec id="sec3.4">
        <title>ChIP</title>
        <p>ChIP was performed as described (<xref rid="bib25" ref-type="bibr">Lusic et al., 2003</xref>). To detect chromosomal flanking regions, pellets were sonicated (Bioruptor sonicator) to obtain fragments of 1–1.5 kb. ChIP antibodies are as follows: Pol II (H224), USF (C20), and CDK9 (H-169) (Santa Cruz); Pol II Ser2P (H5) and Ser5P (H14) (Covance). Diluted input concentrations (1/10 and 1/100) were used as standards for each primer and TaqMan probe set. Real-time PCR used TaqMan technology (AbiPrism 7000; Applied Biosystems), standardized to primer efficiency. Fold antibody enrichment (occupancy) was calculated as a percent of input material, normalized to an unrelated genomic region (B13; <xref rid="bib25" ref-type="bibr">Lusic et al., 2003</xref>). Primer sequences are available on request.</p>
      </sec>
      <sec id="sec3.5">
        <title>3C and p3C</title>
        <p>3C (<xref rid="bib38" ref-type="bibr">Tolhuis et al., 2002</xref>) was performed on 5 × 10<sup>7</sup> U1 cells with modifications (<xref rid="bib39" ref-type="bibr">Vakoc et al., 2005</xref>). For p3C analysis, HeLa cells (2 × 10<sup>7</sup>) were crosslinked as described (<xref rid="bib38" ref-type="bibr">Tolhuis et al., 2002</xref>). Nuclei were isolated by centrifuging for 5 min at 13,000 rpm were resuspended in 500 μl lysis buffer (10 mM Tris [pH 8.0], 10 mM NaCl, and 0.2% NP-40), underlayed with lysis buffer + 24% sucrose and centrifuged for 5 min at 13,000 rpm. This step was repeated twice, once with 20% sucrose, and then nuclei were resuspended in 750 μl 1× restriction buffer. Fifty microliters of nuclei was digested with 800 U of BanI or HindIII (NEB) at 37°C overnight, with subsequent steps as previously described (<xref rid="bib39" ref-type="bibr">Vakoc et al., 2005</xref>), except p3C products were column purified (QIAGEN) instead of precipitated. 3C and p3C templates were resuspended/eluted in a total volume of 200/100 μl TE, respectively. Note: p3C analysis using primers p2 and p4 (<xref rid="fig3" ref-type="fig">Figures 3</xref>Bd and 3Be) used 100 μl nuclei in 50 μl elution volume. Two microliters of input was used in a standardized PCR reaction of 32 cycles of 95°C for 45 s, 58°C for 45 s, 72°C for 1 min, and final extension for 5 min at 72°C. HIV-1 internal PCR controls were obtained by PCR amplification using 1 μg U1 genomic DNA/pNL4-3 as above, column purified, and quantified to supply a random pool of religated products. Equimolar amounts of PCR products were digested 5 hr at 37°C and ligated overnight at 4°C, and a 1/500 dilution was used for agarose gel analysis. Real-time (qRT-PCR) 3C used 2 μl of input in triplicate (Corbett Rotor-Gene 3000 with QuantiTect SYBR Green [QIAGEN)). Agarose PCR products were quantified with ImageQuant IQ Tools Version 2.2 (Amersham). qRT-PCR products were analyzed with Rotor-Gene6 software and standardized to (1) relative primer efficiency and (2) values from internal HIV-1 PCR products (primers flanking the nt3625 BanI site for HindIII and nt 3525–3760 for BanI analysis). 3C/p3C primer details are available on request.</p>
      </sec>
    </sec>
    <sec id="app1" sec-type="supplementary-material">
      <title>Supplemental Data</title>
      <p>Supplemental Data include Supplemental Experimental Procedures and five figures and can be found with this article online at <ext-link xlink:href="http://www.molecule.org/cgi/content/full/29/1/56/DC1/" ext-link-type="uri">http://www.molecule.org/cgi/content/full/29/1/56/DC1/</ext-link>.</p>
    </sec>
    <sec id="app2" sec-type="supplementary-material">
      <title>Supplemental Data</title>
      <p>
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Document S1. Supplemental Experimental Procedures and Five Figures</title>
          </caption>
          <media xlink:href="mmc1.pdf" mimetype="application" mime-subtype="pdf"/>
        </supplementary-material>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank M. Martin (Division of AIDS, NIAID, NIH) for pNL4-3 and pNL4-3.R-E- and Q. Sattentau and W. James (SWDSOP, Oxford) for critically reading the manuscript. This work was supported by programme grants from the Medical Research Council and Wellcome Trust (N.J.P.) and the National Research Programme on AIDS of the Instituto Superiore di Sanità, Italy (M.G.). K.J.P. performed 3C, p3C, chromosomal mapping, and mutational analyses, and M.L. performed ChIP analyses and U1 cell growth experiments.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>Adachi et al., 1986</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adachi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Gendelman</surname>
              <given-names>H.E.</given-names>
            </name>
            <name>
              <surname>Koenig</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Folks</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Willey</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Rabson</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone</article-title>
          <source>J. Virol.</source>
          <year>1986</year>
          <volume>59</volume>
          <fpage>284</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="pmid">3016298</pub-id>
        </citation>
      </ref>
      <ref id="bib2">
        <label>Ansari and Hampsey, 2005</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ansari</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hampsey</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>A role for the CPF 3′-end processing machinery in RNAP II-dependent gene looping</article-title>
          <source>Genes Dev.</source>
          <year>2005</year>
          <volume>19</volume>
          <fpage>2969</fpage>
          <lpage>2978</lpage>
          <pub-id pub-id-type="pmid">16319194</pub-id>
        </citation>
      </ref>
      <ref id="bib3">
        <label>Ashe et al., 1995</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ashe</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Griffin</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Proudfoot</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site</article-title>
          <source>Genes Dev.</source>
          <year>1995</year>
          <volume>9</volume>
          <fpage>3008</fpage>
          <lpage>3025</lpage>
          <pub-id pub-id-type="pmid">7498796</pub-id>
        </citation>
      </ref>
      <ref id="bib4">
        <label>Ashe et al., 1997</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ashe</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Pearson</surname>
              <given-names>L.H.</given-names>
            </name>
            <name>
              <surname>Proudfoot</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>The HIV-1 5′ LTR poly(A) site is inactivated by U1 snRNP interaction with the downstream major splice donor site</article-title>
          <source>EMBO J.</source>
          <year>1997</year>
          <volume>16</volume>
          <fpage>5752</fpage>
          <lpage>5763</lpage>
          <pub-id pub-id-type="pmid">9312033</pub-id>
        </citation>
      </ref>
      <ref id="bib5">
        <label>Ashe et al., 2000</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ashe</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Furger</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Proudfoot</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>Stem-loop 1 of the U1 snRNP plays a critical role in the suppression of HIV-1 polyadenylation</article-title>
          <source>RNA</source>
          <year>2000</year>
          <volume>6</volume>
          <fpage>170</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="pmid">10688356</pub-id>
        </citation>
      </ref>
      <ref id="bib6">
        <label>Binnie et al., 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Binnie</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Castelo-Branco</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Monks</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Proudfoot</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>Homologous gene sequences mediate transcription-domain formation</article-title>
          <source>J. Cell Sci.</source>
          <year>2006</year>
          <volume>119</volume>
          <fpage>3876</fpage>
          <lpage>3887</lpage>
          <pub-id pub-id-type="pmid">16940354</pub-id>
        </citation>
      </ref>
      <ref id="bib7">
        <label>Bohnlein et al., 1989</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bohnlein</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hauber</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Cullen</surname>
              <given-names>B.R.</given-names>
            </name>
          </person-group>
          <article-title>Identification of a U5-specific sequence required for efficient polyadenylation within the human immunodeficiency virus long terminal repeat</article-title>
          <source>J. Virol.</source>
          <year>1989</year>
          <volume>63</volume>
          <fpage>421</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="pmid">2908926</pub-id>
        </citation>
      </ref>
      <ref id="bib8">
        <label>Bres et al., 2005</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bres</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Gomes</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Pickle</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>K.A.</given-names>
            </name>
          </person-group>
          <article-title>A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat</article-title>
          <source>Genes Dev.</source>
          <year>2005</year>
          <volume>19</volume>
          <fpage>1211</fpage>
          <lpage>1226</lpage>
          <pub-id pub-id-type="pmid">15905409</pub-id>
        </citation>
      </ref>
      <ref id="bib9">
        <label>Cai et al., 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cai</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Kohwi-Shigematsu</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes</article-title>
          <source>Nat. Genet.</source>
          <year>2006</year>
          <volume>38</volume>
          <fpage>1278</fpage>
          <lpage>1288</lpage>
          <pub-id pub-id-type="pmid">17057718</pub-id>
        </citation>
      </ref>
      <ref id="bib10">
        <label>Cannon et al., 1994</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cannon</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Ulich</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2</article-title>
          <source>J. Virol.</source>
          <year>1994</year>
          <volume>68</volume>
          <fpage>1993</fpage>
          <lpage>1997</lpage>
          <pub-id pub-id-type="pmid">8107261</pub-id>
        </citation>
      </ref>
      <ref id="bib11">
        <label>Chao and Price, 2001</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chao</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>D.H.</given-names>
            </name>
          </person-group>
          <article-title>Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo</article-title>
          <source>J. Biol. Chem.</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>31793</fpage>
          <lpage>31799</lpage>
          <pub-id pub-id-type="pmid">11431468</pub-id>
        </citation>
      </ref>
      <ref id="bib12">
        <label>Chun et al., 1997</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chun</surname>
              <given-names>T.W.</given-names>
            </name>
            <name>
              <surname>Carruth</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Finzi</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>DiGiuseppe</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hermankova</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Chadwick</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Margolick</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Quinn</surname>
              <given-names>T.C.</given-names>
            </name>
          </person-group>
          <article-title>Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>387</volume>
          <fpage>183</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">9144289</pub-id>
        </citation>
      </ref>
      <ref id="bib13">
        <label>Deichmann et al., 1997</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deichmann</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bentz</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Ultra-sensitive FISH is a useful tool for studying chronic HIV-1 infection</article-title>
          <source>J. Virol. Methods</source>
          <year>1997</year>
          <volume>65</volume>
          <fpage>19</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">9128858</pub-id>
        </citation>
      </ref>
      <ref id="bib14">
        <label>Dekker et al., 2002</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dekker</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rippe</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Dekker</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kleckner</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Capturing chromosome conformation</article-title>
          <source>Science</source>
          <year>2002</year>
          <volume>295</volume>
          <fpage>1306</fpage>
          <lpage>1311</lpage>
          <pub-id pub-id-type="pmid">11847345</pub-id>
        </citation>
      </ref>
      <ref id="bib15">
        <label>Emiliani et al., 1998</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Emiliani</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fischle</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Ott</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Van Lint</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Amella</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Verdin</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line</article-title>
          <source>J. Virol.</source>
          <year>1998</year>
          <volume>72</volume>
          <fpage>1666</fpage>
          <lpage>1670</lpage>
          <pub-id pub-id-type="pmid">9445075</pub-id>
        </citation>
      </ref>
      <ref id="bib16">
        <label>Folks et al., 1987</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Folks</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Justement</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kinter</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Dinarello</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Fauci</surname>
              <given-names>A.S.</given-names>
            </name>
          </person-group>
          <article-title>Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line</article-title>
          <source>Science</source>
          <year>1987</year>
          <volume>238</volume>
          <fpage>800</fpage>
          <lpage>802</lpage>
          <pub-id pub-id-type="pmid">3313729</pub-id>
        </citation>
      </ref>
      <ref id="bib17">
        <label>Fraser, 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fraser</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Transcriptional control thrown for a loop</article-title>
          <source>Curr. Opin. Genet. Dev.</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>490</fpage>
          <lpage>495</lpage>
          <pub-id pub-id-type="pmid">16904310</pub-id>
        </citation>
      </ref>
      <ref id="bib18">
        <label>Furger et al., 2001</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Furger</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Monks</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Proudfoot</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>The retroviruses human immunodeficiency virus type 1 and Moloney murine leukemia virus adopt radically different strategies to regulate promoter-proximal polyadenylation</article-title>
          <source>J. Virol.</source>
          <year>2001</year>
          <volume>75</volume>
          <fpage>11735</fpage>
          <lpage>11746</lpage>
          <pub-id pub-id-type="pmid">11689654</pub-id>
        </citation>
      </ref>
      <ref id="bib19">
        <label>Giacca et al., 1992</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giacca</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gutierrez</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>Menzo</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>d'Adda di Fagagna</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Falaschi</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1</article-title>
          <source>Virology</source>
          <year>1992</year>
          <volume>186</volume>
          <fpage>133</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">1727595</pub-id>
        </citation>
      </ref>
      <ref id="bib20">
        <label>Gomes et al., 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gomes</surname>
              <given-names>N.P.</given-names>
            </name>
            <name>
              <surname>Bjerke</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Llorente</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Szostek</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Emerson</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Espinosa</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program</article-title>
          <source>Genes Dev.</source>
          <year>2006</year>
          <volume>20</volume>
          <fpage>601</fpage>
          <lpage>612</lpage>
          <pub-id pub-id-type="pmid">16510875</pub-id>
        </citation>
      </ref>
      <ref id="bib21">
        <label>Han et al., 2004</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wind-Rotolo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kirkman</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Morrow</surname>
              <given-names>C.D.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site</article-title>
          <source>Virology</source>
          <year>2004</year>
          <volume>330</volume>
          <fpage>221</fpage>
          <lpage>232</lpage>
          <pub-id pub-id-type="pmid">15527848</pub-id>
        </citation>
      </ref>
      <ref id="bib22">
        <label>Jeang et al., 1993</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jeang</surname>
              <given-names>K.T.</given-names>
            </name>
            <name>
              <surname>Chun</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>N.H.</given-names>
            </name>
            <name>
              <surname>Gatignol</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Glabe</surname>
              <given-names>C.G.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor</article-title>
          <source>J. Virol.</source>
          <year>1993</year>
          <volume>67</volume>
          <fpage>6224</fpage>
          <lpage>6233</lpage>
          <pub-id pub-id-type="pmid">7690421</pub-id>
        </citation>
      </ref>
      <ref id="bib23">
        <label>Lee et al., 2002</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Shim</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Seo</surname>
              <given-names>H.K.</given-names>
            </name>
            <name>
              <surname>Kyhm</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>Y.H.</given-names>
            </name>
          </person-group>
          <article-title>Molecular cytogenetic analysis of the monoblastic cell line U937. karyotype clarification by G-banding, whole chromosome painting, microdissection and reverse painting, and comparative genomic hybridization</article-title>
          <source>Cancer Genet. Cytogenet.</source>
          <year>2002</year>
          <volume>137</volume>
          <fpage>124</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="pmid">12393283</pub-id>
        </citation>
      </ref>
      <ref id="bib24">
        <label>Levitt et al., 1989</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levitt</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Briggs</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Gil</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Proudfoot</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>Definition of an efficient synthetic poly(A) site</article-title>
          <source>Genes Dev.</source>
          <year>1989</year>
          <volume>3</volume>
          <fpage>1019</fpage>
          <lpage>1025</lpage>
          <pub-id pub-id-type="pmid">2570734</pub-id>
        </citation>
      </ref>
      <ref id="bib25">
        <label>Lusic et al., 2003</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lusic</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Marcello</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Cereseto</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Giacca</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter</article-title>
          <source>EMBO J.</source>
          <year>2003</year>
          <volume>22</volume>
          <fpage>6550</fpage>
          <lpage>6561</lpage>
          <pub-id pub-id-type="pmid">14657027</pub-id>
        </citation>
      </ref>
      <ref id="bib26">
        <label>Marcello et al., 2004</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marcello</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lusic</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pegoraro</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Pellegrini</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Beltram</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Giacca</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Nuclear organization and the control of HIV-1 transcription</article-title>
          <source>Gene</source>
          <year>2004</year>
          <volume>326</volume>
          <fpage>1</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">14729258</pub-id>
        </citation>
      </ref>
      <ref id="bib27">
        <label>Martin et al., 2005</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Cesare</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Griffith</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Attardi</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Termination factor-mediated DNA loop between termination and initiation sites drives mitochondrial rRNA synthesis</article-title>
          <source>Cell</source>
          <year>2005</year>
          <volume>123</volume>
          <fpage>1227</fpage>
          <lpage>1240</lpage>
          <pub-id pub-id-type="pmid">16377564</pub-id>
        </citation>
      </ref>
      <ref id="bib28">
        <label>Meinhart et al., 2005</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meinhart</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kamenski</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hoeppner</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Baumli</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cramer</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>A structural perspective of CTD function</article-title>
          <source>Genes Dev.</source>
          <year>2005</year>
          <volume>19</volume>
          <fpage>1401</fpage>
          <lpage>1415</lpage>
          <pub-id pub-id-type="pmid">15964991</pub-id>
        </citation>
      </ref>
      <ref id="bib29">
        <label>Mellor, 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mellor</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Dynamic nucleosomes and gene transcription</article-title>
          <source>Trends Genet.</source>
          <year>2006</year>
          <volume>22</volume>
          <fpage>320</fpage>
          <lpage>329</lpage>
          <pub-id pub-id-type="pmid">16631276</pub-id>
        </citation>
      </ref>
      <ref id="bib30">
        <label>O'Sullivan et al., 2004</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O'Sullivan</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Tan-Wong</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Morillon</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Coles</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mellor</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Proudfoot</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>Gene loops juxtapose promoters and terminators in yeast</article-title>
          <source>Nat. Genet.</source>
          <year>2004</year>
          <volume>36</volume>
          <fpage>1014</fpage>
          <lpage>1018</lpage>
          <pub-id pub-id-type="pmid">15314641</pub-id>
        </citation>
      </ref>
      <ref id="bib31">
        <label>Peterlin and Price, 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peterlin</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>D.H.</given-names>
            </name>
          </person-group>
          <article-title>Controlling the elongation phase of transcription with P-TEFb</article-title>
          <source>Mol. Cell</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>297</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="pmid">16885020</pub-id>
        </citation>
      </ref>
      <ref id="bib32">
        <label>Pombo et al., 2000</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pombo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Iborra</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Sugaya</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>D.A.</given-names>
            </name>
          </person-group>
          <article-title>Specialized transcription factories within mammalian nuclei</article-title>
          <source>Crit. Rev. Eukaryot. Gene Expr.</source>
          <year>2000</year>
          <volume>10</volume>
          <fpage>21</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">10813391</pub-id>
        </citation>
      </ref>
      <ref id="bib33">
        <label>Proudfoot et al., 2002</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Proudfoot</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>Furger</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Dye</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Integrating mRNA processing with transcription</article-title>
          <source>Cell</source>
          <year>2002</year>
          <volume>108</volume>
          <fpage>501</fpage>
          <lpage>512</lpage>
          <pub-id pub-id-type="pmid">11909521</pub-id>
        </citation>
      </ref>
      <ref id="bib34">
        <label>Simonis et al., 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simonis</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Klous</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Splinter</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Moshkin</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Willemsen</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>de Wit</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>van Steensel</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>de Laat</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C)</article-title>
          <source>Nat. Genet.</source>
          <year>2006</year>
          <volume>38</volume>
          <fpage>1348</fpage>
          <lpage>1354</lpage>
          <pub-id pub-id-type="pmid">17033623</pub-id>
        </citation>
      </ref>
      <ref id="bib35">
        <label>Singh and Hampsey, 2007</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>B.N.</given-names>
            </name>
            <name>
              <surname>Hampsey</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>A transcription-Independent Role for TFIIB in Gene Looping</article-title>
          <source>Mol. Cell</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>806</fpage>
          <lpage>816</lpage>
          <pub-id pub-id-type="pmid">17803944</pub-id>
        </citation>
      </ref>
      <ref id="bib36">
        <label>Splinter et al., 2004</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Splinter</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Grosveld</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>de Laat</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>3C technology: analyzing the spatial organization of genomic loci in vivo</article-title>
          <source>Methods Enzymol.</source>
          <year>2004</year>
          <volume>375</volume>
          <fpage>493</fpage>
          <lpage>507</lpage>
          <pub-id pub-id-type="pmid">14870685</pub-id>
        </citation>
      </ref>
      <ref id="bib37">
        <label>Thomas and Chiang, 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thomas</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Chiang</surname>
              <given-names>C.M.</given-names>
            </name>
          </person-group>
          <article-title>The general transcription machinery and general cofactors</article-title>
          <source>Crit. Rev. Biochem. Mol. Biol.</source>
          <year>2006</year>
          <volume>41</volume>
          <fpage>105</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="pmid">16858867</pub-id>
        </citation>
      </ref>
      <ref id="bib38">
        <label>Tolhuis et al., 2002</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tolhuis</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Palstra</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Splinter</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Grosveld</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>de Laat</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Looping and interaction between hypersensitive sites in the active beta-globin locus</article-title>
          <source>Mol. Cell</source>
          <year>2002</year>
          <volume>10</volume>
          <fpage>1453</fpage>
          <lpage>1465</lpage>
          <pub-id pub-id-type="pmid">12504019</pub-id>
        </citation>
      </ref>
      <ref id="bib39">
        <label>Vakoc et al., 2005</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vakoc</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Letting</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Gheldof</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sawado</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Bender</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Groudine</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Dekker</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Blobel</surname>
              <given-names>G.A.</given-names>
            </name>
          </person-group>
          <article-title>Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1</article-title>
          <source>Mol. Cell</source>
          <year>2005</year>
          <volume>17</volume>
          <fpage>453</fpage>
          <lpage>462</lpage>
          <pub-id pub-id-type="pmid">15694345</pub-id>
        </citation>
      </ref>
      <ref id="bib40">
        <label>West and Fraser, 2005</label>
        <citation citation-type="other">West, A. G., and Fraser, P. (2005). Remote control of gene transcription. Hum. Mol. Genet. <italic>14 Spec No 1</italic>, R101–R111.</citation>
      </ref>
      <ref id="bib41">
        <label>Zhao et al., 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Tavoosidana</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Sjolinder</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gondor</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mariano</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kanduri</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lezcano</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Singh Sandhu</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions</article-title>
          <source>Nat. Genet.</source>
          <year>2006</year>
          <volume>38</volume>
          <fpage>1341</fpage>
          <lpage>1347</lpage>
          <pub-id pub-id-type="pmid">17033624</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <fig id="fig1">
      <label>Figure 1</label>
      <caption>
        <p>Characterization of Integrated HIV-1 Provirus in U1 Cells</p>
        <p>(A) (a) HIV-1 mRNA accumulation using qRT-PCR analysis. Values were normalized to 18S rRNA and expressed as a fold induction over untreated U1 cells. (b) Location of ChIP primers relative to the transcription start site (+1) are depicted. Nuc, nucleosomes present on the 5′LTR of latent provirus. Note: P1 does not distinguish between the two LTRs. (c) Pol II qChIP on control (white bars) and TPA-activated U1 cells after 5 (black bars) and 24 hr (gray bars) using the indicated primer and probe sets. Binding was measured relative to B13 (see <xref rid="sec3" ref-type="sec">Experimental Procedures</xref>). Error bars represent SEM from n = 3 samples performed in duplicate for each primer set.</p>
        <p>(B) HIV-1 proviral characterization using iPCR. (a) iPCR primer locations and restriction sites: gray, outer primers; black, nested primers. Open arrows illustrate 3′ HIV-proviral/host cell DNA junctions used to confirm integrate location (see <xref rid="sec3" ref-type="sec">Experimental Procedures</xref>). (b) Nested U1 genomic DNA PCR products (+; with Taq polymerase) for integration site mapping and determination of Tat sequences for int-Chr2 (Chr2; Tat1<sub>U1</sub>) and int-ChrX (ChrX; Tat2<sub>U1</sub>).</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Figure 2</label>
      <caption>
        <p>Integrated U1 HIV-1 Proviruses Form Quantitatively Different Looping Conformations</p>
        <p>(A) Representation of integrated provirus and flanking chromosomal sequence with restriction enzyme sites and primers for BanI and HindIII 3C analysis. Numbers denote distance from 5′ (−) or 3′ (+) proviral ends. Arrows indicate primer direction and name; black/gray arrows refer to primers that detect LTR and the MSD, respectively. HIV-1 long-terminal repeat (LTR) regions (U3, R, and U5), MSD, and polyadenylation sites (pA) are indicated.</p>
        <p>(B) int-ChrX 3C. Unstimulated (−TPA), cells after 5 hr TPA (+TPA), and control PCR panel (control). Positive lanes (+) signify internal HIV-1 PCR controls on U1 gDNA (control panel) and chromatin (for −/+TPA; see <xref rid="sec3" ref-type="sec">Experimental Procedures</xref>). Common PCR primers are shown above the figure, with the second primer shown above each lane. Graphs below represent quantified percentages of 3C product observed compared to PCR control, standardized between − and +TPA samples (using internal PCR controls; see + lane).</p>
        <p>(C) Quantitative analysis of Tat- or TPA-induced int-ChrX and int-Chr2 loop structures. (a) HIV-1 qRT-PCR at 0, 3, and 5 hr post-TPA treatment with nuc1 primers (<xref rid="fig1" ref-type="fig">Figure 1</xref>A) standardized to 18S rRNA transcription. (b) q3C HindIII-digested U1 chromatin analysis; primers used to detect the “loop”: interaction (primers 22/23 for int-Chr2 and X2/X3 for int-ChrX) compared to the adjacent amplified fragment (primers 22/H7 or X2/H7).</p>
        <p>(D) (a) HIV-1 qRT-PCR treated with 0 (10 μg GFP control), 5, or 10 μg of GFP-tagged Tat protein. (b) q3C HindIII analysis of U1 chromatin treated with 10 μg Tat-GFP or GFP. Error bars represent SEM from n = 6 samples from two separate chromatin preparations (except 22/23 and X2/X3 in Tat induction analysis where n = 9, from three separate chromatin preparations).</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Figure 3</label>
      <caption>
        <p>p3C Analysis Indicates HIV-1 Loop Formation Occurs on a Plasmid Template</p>
        <p>(A) (a) RT-PCR analysis of pNL4-3-transfected HeLa cell RNA detecting HIV-1-specific transcripts. HIV, HIV-1 primers; act, actin control primers; M, DNA marker; pUC18, vector backbone, − or + RT. (b) p3C BanI restriction sites and primer position and direction are numbered as in <xref rid="fig2" ref-type="fig">Figure 2</xref>A; black and gray arrows denote primers corresponding to LTR and MSD regions, respectively; and plasmid-specific primers are allocated according to the BanI position from the 5′ (−) 3′ (+) proviral ends.</p>
        <p>(B) BanI p3C analysis shows LTR-LTR and LTR/MSD juxtaposition. Positive PCR panels (control) were used to demonstrate that primer sets amplify correct products. + lane signifies internal HIV-1 PCR controls; common PCR primers are shown above the figure and second primers above each lane. Significant 3C products (<sup>∗</sup>) and those derived from adjacent fragment ligation (X) are denoted. Graphs below represent quantified percentage of 3C product observed compared to PCR control, as per <xref rid="fig2" ref-type="fig">Figure 2</xref>B (note: chromatin preparations for p2 (d) and p4 (e) were concentrated as outlined in the <xref rid="sec3" ref-type="sec">Experimental Procedures</xref>).</p>
        <p>(C) 3C and p3C summary. HIV-1 provirus with restriction sites present in pNL4-3, int-ChrX, int-Chr2, and their flanking regions are as indicated. Major LTR-LTR interactions are shown in black; regions showing partial interaction are in gray. Lower brackets define minimal interacting regions from combined 3C and p3C data.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Figure 4</label>
      <caption>
        <p>Occupancy of Pol II and Associated Factors across Transcriptionally Active Provirus and Flanking Chromosomal Regions</p>
        <p>(A) Asymmetric distribution of Pol II Ser5P (a) Ser2P (b), CDK9 (c), and USF (d) association was determined by qChIP assay in control (white bars) and 5 hr TPA-activated U1 cells (black bars). Immunoprecipitated DNA was analyzed by real-time PCR using the primer sets as described in <xref rid="fig1" ref-type="fig">Figure 1</xref>. ChIP signal levels are not comparable between antibodies. Note: P1 does not distinguish between the two LTRs.</p>
        <p>(B) Flanking chromosomal analysis of proviral integrates indicates differential response to TPA stimulation for (a) int-ChrX and (b) int-Chr2. Error bars represent SEM from n = 3 samples performed in duplicate for each primer set.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="fig5">
      <label>Figure 5</label>
      <caption>
        <p>Flavopiridol Inactivates HIV-1 Transcription by Blocking CTD Ser2P and Ser5p, Leading to Loss of Gene Loop Structure</p>
        <p>(A) (a) HIV-1 mRNA levels (qRT-PCR) and (b) q3C (see <xref rid="fig2" ref-type="fig">Figure 2</xref>) prior to (white bar) or after 16 hr TPA treatment (black bar) followed by 5 hr of flavopiridol treatment (500 nM; gray bar).</p>
        <p>(B–F) qChIP analysis for total RNAP II, Ser5P, Ser2P, CDK9, and USF respectively was performed for control (white bars), transcriptionally active (TPA induced; black bars), and transcriptionally blocked (flavopiridol treatment after TPA induction) U1 cells (gray bars). ChIP signal levels are not comparable between antibodies. P1 primers amplified from both 5′ and 3′LTR DNA. Error bars represent SEM from n = 3 samples performed in duplicate for each primer set, except primers 22/23 and X2/X3 (n = 12), which are from four separate chromatin preparations.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <fig id="fig6">
      <label>Figure 6</label>
      <caption>
        <p>Functional MSD and 3′LTR Poly(A) Signals Are Required for Transcription-Dependent Loop Formation of pNL4 HIV-1 Provirus</p>
        <p>(A) (a) pNL4 5′ end mutant constructs used in p3C analysis showing primers used to detect HIV-1 LTR or CMV promoter (p3) and the major splice donor (MSD; B1). Primer numbering and positions, poly(A), LTR, and MSD regions are as in <xref rid="fig3" ref-type="fig">Figure 3</xref>. Arrows indicate transcription start sites. (b) Real-time q-p3C analysis of comparative loop formation using primer p3 (5′LTR) using pNL4, derivatives pNL4-luc, and pNL4.msd and (c) pNL4-luc compared to the CMV promoter construct pNL4-luc.CMV.</p>
        <p>(B) (a) pNL4-luc 3′ end poly(A) and SPA constructs used in p3C analysis; primer numbering and positions are as in <xref rid="fig3" ref-type="fig">Figure 3</xref>, with luciferase (luc+) reporter gene, poly(A), and LTR regions as shown. Real-time q-p3C analysis of comparative loop formation using primer p3 (5′LTR) in analysis of the SPA wild-type and mutant (b) HIV-1 poly(A) and DSE mutants (c). Asterisks denote absence of the B4 primer binding site for SPA constructs. For all graphs, dotted lines show values of pNL4-luc obtained for 5′LTR/MSD and 5′LTR/3′ end (3′LTR) products with (+) or without (−) cotransfected Tat expression vector. Primer p3 was used in combination with the primers depicted below all graphs. Error bars represent SEM between values from separate chromatin preparations performed in triplicate (n = 6), except for p3/B1 (n = 12) and p3/p2 (n = 15).</p>
      </caption>
      <graphic xlink:href="gr6"/>
    </fig>
    <fig id="fig7">
      <label>Figure 7</label>
      <caption>
        <p>Ribbon Diagrams Illustrating HIV-1 Interactions as Determined by 3C Analysis</p>
        <p>(A) Potential interactions in the HIV-1 proviral sequence upon TPA or Tat stimulation for int-ChrX. Also illustrated is the hypothesized conformation of pNL4-3 in (B) wild-type (C) in the absence of a functional 3′ end poly(A) signal (as evidenced by the HIV-1 poly[A] and SPA mutants) and (D) without a functional MSD. Dashed lines represent transcription (with gray and white circles denoting promoter/poly[A] sites respectively), with LTRs, MSD, and poly(A) hexamer as indicated.</p>
      </caption>
      <graphic xlink:href="gr7"/>
    </fig>
  </floats-wrap>
</article>